“New Covid Variant ‘Nimbus’ Under WHO Watch: Here’s What You Need to Know”

A newly emerging COVID-19 variant, NB.1.8.1, informally known as Nimbus, is gaining global attention due to its rapid spread and unusual symptom described as “razor blade throat”. First identified in January 2025, this Omicron descendant has been flagged by the World Health Organization (WHO) as one of six variants under close observation. As infections rise across the US, UK, and parts of Asia, experts are monitoring its transmissibility, severity, and impact on public health systems.

Why in News?

The WHO has listed NB.1.8.1 (Nimbus) as a variant under monitoring, due to its fast-growing prevalence. Described by some patients as causing extremely painful sore throats, the variant has triggered renewed caution globally. India has reported COVID-related deaths, but not specific cases of Nimbus yet, as per current sequencing data. Public concern is growing due to viral descriptions of “razor blade throat” and a new subvariant XFG (Stratus) circulating alongside Nimbus.

Key Facts

  • Variant Name: NB.1.8.1 (Nimbus)
  • Lineage: Descendant of Omicron
  • First Identified: January 2025
  • Symptom Highlight: “Razor blade throat” – intense sore throat
  • Detected In: 13 US states, UK, China, Singapore, Thailand, India (monitoring stage)
  • Global Presence: Detected in 22 countries, accounting for 10.7% of sequenced cases (April 21–27, 2025)

Symptoms (Similar to Omicron)

  • Cough, fever, headache, fatigue, congestion
  • Muscle aches, nausea or vomiting
  • Loss of taste/smell
  • Severe sore throat in some cases (“razor blade throat”)

What Is “Razor Blade Throat”?

  • Not a medical term, but a popular description of severe throat pain
  • Feels like glass shards in the throat
  • Common in other viral and bacterial infections as well

Is Nimbus Dangerous?

  • WHO risk level: Low
  • Causes mild to moderate illness
  • No major surge in hospitalizations or deaths reported yet
  • Current vaccines remain effective

India’s Situation

  • Daily cases: 100–200, stable as per Dr Arup Halder
  • No confirmed Nimbus cases, but authorities are cautious
  • Rise in respiratory illnesses due to H3N2 and adenovirus
  • ICMR urges testing for severe symptoms, especially in vulnerable groups

Other Variant – XFG (Stratus)

  • Another fast-spreading Omicron subvariant
  • Not currently under WHO monitoring
  • Fewer sequenced cases compared to Nimbus
Summary/Static Details
Why in the news? “New Covid Variant ‘Nimbus’ Under WHO Watch: Here’s What You Need to Know”
Variant Name NB.1.8.1, nicknamed Nimbus
WHO Status Variant under monitoring
Primary Symptom Highlight “Razor blade throat” (painful sore throat)
Detected Regions US (13 states), UK, parts of Asia, India (not confirmed)
Public Health Risk Assessed as Low by WHO
Vaccines Still effective against this variant
India Status Stable COVID cases, no confirmed Nimbus cases

Shivam

As a Content Executive Writer at Adda247, I am dedicated to helping students stay ahead in their competitive exam preparation by providing clear, engaging, and insightful coverage of both major and minor current affairs. With a keen focus on trends and developments that can be crucial for exams, researches and presents daily news in a way that equips aspirants with the knowledge and confidence they need to excel. Through well-crafted content, Its my duty to ensures that learners remain informed, prepared, and ready to tackle any current affairs-related questions in their exams.

Recent Posts

Weekly Current Affairs One Liners 16th to 22nd of February 2026

Weekly Current Affairs One-Liners Current Affairs 2026 plays a very important role in competitive examinations…

2 hours ago

Which District is known as the Medical City of Uttar Pradesh?

Did you know that one district in Uttar Pradesh is famous for its advanced hospitals…

21 hours ago

Which was the First Women’s University in India? Where it is Located?

Did you know that there was a time when girls in India were not allowed…

21 hours ago

L&T Vyoma to Study 250 MW Green AI Data Centre at Dholera SIR

At India AI Impact Summit 2026, the Gujarat government signed a Memorandum of Understanding (MoU)…

24 hours ago

Made in India: Nadda Launches Indigenous Td Vaccine at Kasauli Centre

Union Health Minister Jagat Prakash Nadda launched the indigenously manufactured Tetanus and Adult Diphtheria (Td)…

24 hours ago

Which Island is known as the Island of Pepper?

Did you know that one small island became famous across the world because of a…

24 hours ago